2018 European Summit Speaker Biographies

Sandy Balkin, Ph.D.

Senior Director, Global Insights and Analytics, Sanofi

Sandy Balkin, Ph.D. is Senior Director, Global Insights and Analytics with Sanofi. He is responsible for the identification, development and scaling of new data and analytic capabilities that support R&D, medical and commercial decision making.

Prior to joining Sanofi, Sandy built best-in-class analytics functions at two consultancies as Vice President of Analytics and Commercial Effectiveness with Aptus Health and as Senior Principal with Precision for Value. Prior to that, Sandy held a number of roles of increasing responsibility at Boehringer-Ingelheim where he was Executive Director, Forecasting and Business Analytics and at Pfizer as Director/Team Leader of Predictive Modeling, building and leading teams responsible for providing forecasting and strategic support to key corporate functions including BD&L, marketing, finance, market research, new product planning and sales.

Sandy has a Ph.D. in Business Administration from Penn State University. He also holds a Master of Arts in Statistics from Penn State University, as well as a Bachelor of Arts Degree in Mathematics and Economics and Music from Lafayette College where he graduated with honors.

Kanishka Chatterjee

Assistant Vice President, Genpact

Kanishka Chatterjee is an Assistant Vice President at Genpact with 12 years of experience in marketing and digital media analytics. He has spent the last 8 years focusing on how social media and digital marketing proactiveness helps transform ‘performance marketing’ across verticals – for both direct to consumer and B2B. He’s part of Genpact’s Digital Marketing and Emergent Channel Analytics practice and is an expert in digital marketing measurement, multichannel attribution, micro-segmentation & personalization, customer journey mapping (including patient pathways) and strategic insight mining from unstructured data

Michel Denarie

Senior Principal, Data Scientist, Strategic Drug Development, IQVIA

Michel Denarié, after serving for several years as global COE for Patient Insights, recently joined the Strategic Drug Development team at IQVIA, a group that designs clinical trials, develops clinical development plans, reviews protocols, and conducts licensing candidate due diligence for biopharma sponsors. He is leveraging the various secondary data assets available across the globe to enhance trial design, protocol validation, country selection, and accelerate patient recruitment . His area of expertise covers all the legacy IQVIA real world data assets that can be leveraged world-wide to support clinical development. Denarié received his MS from American University and MBA from the Darden School of Business, University of Virginia.

Martim Goncalves

Global Solutions Manager, IQVIA

Martim Goncalves is a Project Manager with +10 years' experience in Pharma, Financial Services, and Energy at Roche, Novartis, Deloitte Consulting (Strategy & Ops), and UMS Advisory. Martim has led transformation projects (cost-cutting, efficiency improvement) and revenue-enhancement engagements (business development , sales revamp) in Europe, Latin America and Africa. He is business proficient in five languages with an MBA from IESE Business School.

Michael Heupel, MSc, MBA

Director, Market Access, GfK

Michael moved into Market Access consultancy at GfK in 2018. He brings extensive international pharma and consultancy experience with strategic mind setting. He has gained considerable insights into health systems across Europe prior to GFK. Michael has conducted many market access due diligence projects as well as optimal pricing and reimbursement processes during the launch of new pipeline products. Furthermore he is skilled in field based Market Access value communication and payer engagement.

Michael is specialised in the development and execution of customer strategies led cross-functional teams within Business Development and Market Access projects. Previous roles include working for AstraZeneca as Pricing Implementation Manager as well as Strategy Consultant for a Big Four consulting firm. His last assignment was based in Germany working for the private equity firm Riemser Pharma being responsible for all Market Access and commercial executions within the company. Michael has got an MBA from ESCP Business School and a MSc in International Healthcare Management.

Yasemin Ilgin, PhD, MSc

Associated Data Science Director, IQVIA

Yasemin Ilgin is Associate Data Science Director with expertise in advanced analytics and has been a key resource in developing the new global survey frame for IQVIA Oncology offerings. In the last years she focused on offering development making use of advanced analytics for EMR (electronic medical records), hospital and pharmacy data with a regional responsibility for Germany. Some typical projects included predictive analytics using supervised and unsupervised Machine Learning approaches, time-series forecasting, Markov Chain and survival analysis modeling, and clinical indicator development. Yasemin owns MSc degrees in Economics and Psychology, a PhD in Economics with focus on Health Economics and is a certified Systemic Business Coach. Before joining IQVIA in 2007 as an academic research scientist she reviewed international measures of price regulation and carried out various empirical studies examining the relation between pharmaceutical innovation, ageing and their influence on health care and pharmaceutical expenditures.

Prathamesh Karmalkar

Senior Data Scientist - Text Mining, NLP, AI & Data Science, GenPact

As a Senior Data Scientist & Solutions Architect, Prathamesh helps articulate client's business problem and develop optimized and robust AI solutions. Solution architecture involves using the Text Mining, Advanced & Contextual Natural Language Processing, Machine Learning, Artificial Intelligence, Big Data & Advanced Analytics. He also guides and mentors Genpact's DS team in building IP and research products for the R&D Labs and supports the product team for building and designing advanced algorithms. He is a Patent Holder for “A System & Method for Online Wireless Electrical Fault & Theft Detection”, and has participated in Patent Research on Sanskrit & Hindi NLP, Text Mining & Artificial Intelligence.

Shubham Lahoti

Associate Director, Axtria

Shubham Lahoti has more than 11 years of experience in analytics, modeling, and technology projects with close to 6 years in sales and marketing optimization in the pharma industry. Shubham has managed several sales force analytics projects that involve multi-channel promotional analysis and optimization. He holds a bachelors degree from IIT Bombay.

Shreyas Murthi

Principal, ZS

Shreyas Murthi is a Principal with ZS in the San Francisco, CA office. He has 12+ years of experience in leading a variety of sales and marketing engagements with biopharmaceutical companies, with a focus on specialty therapeutics and Oncology. Shreyas has partnered with clients to address launch issues including forecasting, customer segmentation and targeting, marketing analytics, commercial organization design, incentive compensation, and sales force effectiveness. In addition, Shreyas has significant expertise in using patient level data analytics such as claims and EMR for developing market and customer insights. He has been active with PMSA at conferences and was also featured on a PMSA member spotlight in 2015. Shreyas holds an MBA in Marketing and Strategy from Haas School of Business at University of California at Berkeley. He also has an MS in Management Information Systems from Texas A&M University and a BS in Computer Engineering.

Paul Reuscher

Vice President, Data & Analytics, Decision Resources Group

Paul Reuscher is the Vice President of Data and Analytics at Decision Resources Group. Paul's role involves work on data strategy, acquisition, channel partnerships, and statistical methodology. Paul leads the ongoing data acquisition and partnership strategy that has helped DRG become a "Top 3" healthcare data asset firm in the US. Paul helped pioneer the commercialization strategy and built out the data & analytics business unit to become the fastest growing group within DRG. Prior to working on DRG’s RWE analytics team, Paul was with IMS Health focusing on production management for APLD claims data projects and targeting efforts. In prior years, Paul worked in the health economic consulting space advising Life Science firms and Provider Health Networks across the US. Paul holds a BABS in Economics & Mathematics and a MS in Applied Mathematics.

Igor Rudychev

Sr. Business Insights Director, Immuno-Oncology, AstraZeneca

Igor Rudychev is Sr. Director of Immuno-Oncology Business Insights with AstraZeneca. Igor has over 24 years of analytics experience and for the last 17 years he has been specializing in Pharmaceutical Sales & Marketing Analytics, Business Insights, Resource Allocation, Promotion Response, SF Optimization, Brand Analytics, Patient-Level Data, and Forecasting.

Currently, Igor is responsible for Immuno-Oncology Business Insights & Analytics at AstraZeneca. Prior to joining AstraZeneca Igor was leading Samples Operations, Resource Allocation, Advanced Analytics, and Commercial Assessment & Forecasting at Pfizer. Before Pfizer, Igor was Vice President of Operations with Bayser, a Management Consulting firm in Chicago, where he provided strategic and analytical insights to the top 20 global pharmaceutical companies.

Igor has been a member of PMSA for over 13 years and has presented at multiple PMSA conferences. He has also been published extensively in trade & peer review journals (including ASCO, WCLC, Journal of Clinical Oncology, Journal of Thoracic Oncology, AMCP, MMM, PDT, Phys. Lett., Class. & Quant. Grav., and Nuclear Physics B).

Igor has an MBA from the University of Chicago Booth School of Business and Ph.D. in Theoretical Physics (Superstring Theory & Black Holes) from Texas A&M University.

Igor has served PMSA’s board for three years, as the Professional Development Chair and Research and Education Chair.

Jessica Santos

Global Compliance and Quality Director, Kantar Health

Dr. Jessica Santos is the Global Compliance Director in Kantar Health, a leading global healthcare consulting and market research firm in the life sciences industry. Jessica is primarily responsible for providing oversight and support across the 40+ Kantar Health (KH) global offices in the area of regulation, interaction with clients, suppliers and others within Kantar Health, Kantar and WPP. Dr. Santos is also an experienced statistician, analyst and methodologist. She gained her reputation through her publications and professional committee work in the industry. Jessica is a frequent speaker and contributor in major conferences. She has a PhD in Marketing and MRS fellowship. Dr. Santos is a member of BHBIA Ethics Committee, EphMRA Compliance Network, UK Research Ethics Committee, Insights Association and Intellus Committee, reviewer and chair of ISPOR (International Society of Pharmaco-economic and Outcome Research) Code of Conduct Committee with patient representatives.

Ashish Sharma

Principal, Axtria

Ashish Sharma is an entrepreneur and technology strategist with over 20 years of experience in Big Data, data engineering, and building scalable products. As a principal at Axtria, Ashish unifies the people, process, and technologies of data, analytics, cloud, and machine learning to accelerate the data to insight journey.

Through his work, Ashish leads teams that enable operational efficiencies and business transformations, by building incubators and R&D labs. These efforts have resulted in successful companies, capabilities, and product lines in Big Data, including decision science, data engineering, security, and scalability with focus on business insights, advanced analytics, and customer adaption.

Jennifer Soller

Impact Excellence Lead, Genentech

Jennifer Soller is currently the Impact Excellence Lead for US Medical Affairs at Genentech. She spent the previous 7 years in that company’s Commercial organization, leading teams within the Marketing Science center of excellence. Prior to joining Genentech, she worked in predictive analytics for various industries, including online gaming, investment banking, and the government. She is energized by working on complex, strategic problems that don’t have quick or easy-to-identify solutions, and coaching and mentoring her reports and others to grow and develop.

Cristina Souza

Analytics Data Strategy Lead, Strategic Insights & Analysis, Roche

Cristina Souza is the Analytics Data Strategy Lead working in the Strategic Insights & Analysis department at Roche headquarters in Basel, Switzerland. She has 15 years of experience working in analytics in the pharma industry, in local, regional and global roles. Cristina has worked across a broad number of areas within analytics, including business planning, performance analysis & target setting, portfolio & industry analytics, market research and forecasting. Most recently, she has been leading the SI&A Analytics Partnership Program with ZS, driving the design and implementation of this new model, and working with ZS on how to evolve the program and further build data and analytics capabilities to deliver more value to the Roche global commercial organization. Cristina has a Business degree from Fundação Getulio Vargas and an MBA from Business School São Paulo.

J.P. Tsang

President, Bayser

Jean-Patrick Tsang is the Founder and President of Bayser, a Chicago-based consulting firm dedicated to pharmaceuticals sales and marketing. JP is an expert in patient-level data and related analyses ranging from longitudinal analyses to hospital-retail spillover, KOL identification, influence mapping, referral networks, molecular targeting, promotion response, and the like. JP publishes and talks on a regular basis and runs one-day tutorials several times a year. In a previous life, JP deployed Artificial Intelligence to automate the design of payloads for satellites, methaners, ethaners, and cruise-liners. JP earned a Ph.D. in Artificial Intelligence from Grenoble University and an MBA from INSEAD in France. He was the recipient of the 2015 PMSA Lifetime Achievement Award.

Mark Turner

Principal, ZS Associates

Mark Turner is the EU Customer Centric Marketing (CCM) lead for ZS Europe. He brings over 25 years of direct marketing experience, specializing in the development and operational delivery of data driven, consumer centric strategies. Over the last couple of years, Mark has been helping Pharma companies across region Europe drive value from the delivery of relevant, timely and personalized customer engagement. Most recently, he has led initiatives that design and deploy customer journeys, orchestrated across channels, to improve engagement and experience among HCPs which result in maximizing impact for Pharma clients.

Marisa Pleguezuelo Witte, MD, MS

Associate Statistics Director, Stats Services, IQVIA

Marisa is a medical doctor working in the Global statistical services group supporting medical, oncology and epidemiology studies at IQVIA. Before joining this group, Marisa’s work was focused on medical data, supporting local marketing and client services teams with her medical professional knowledge. Marisa has also worked in developing advanced analytics using IQVIA medical data.

Prior joining IQVIA, Marisa worked as a medical doctor in the UK. She received her MD from the Medical school in Granada, Spain in 1997. After joining IQVIA, she received her MSc in Health Economics from London City University in 2011.

Kaiwen Zhong

Senior Associate, Axtria

Kaiwen is an innovator, focusing on leveraging big data and machine learning to deliver efficiency and insights in pharma. She is a senior associate at Axtria’s Innovation Lab and Big Data team. Prior to Axtria, Kaiwen worked in pharma, finance, and growing startups. She graduated from Cornell University with a Master’s degree focusing on machine learning. Throughout her time at Axtria, Kaiwen has been developing and productizing pharma-specific capabilities for clients in medical affairs, marketing, data, and analytics, through AI, natural language processing, and advanced analytics.